Clinical trials
Hyperlipoproteinemia Type II trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
224 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 4 |
| 2003 | 8 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 9 |
| 2007 | 10 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 7 |
| 2012 | 8 |
| 2013 | 8 |
| 2014 | 9 |
| 2015 | 6 |
| 2016 | 15 |
| 2017 | 12 |
| 2018 | 7 |
| 2019 | 10 |
| 2020 | 7 |
| 2021 | 13 |
| 2022 | 13 |
| 2023 | 14 |
| 2024 | 17 |
| 2025 | 10 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 122 |
| Recruiting | 32 |
| Unknown status | 30 |
| Terminated | 13 |
| Not yet recruiting | 9 |
| Active, not recruiting | 8 |
| Enrolling by invitation | 6 |
| Withdrawn | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 15 |
| Organon and Co | 9 |
| Novartis Pharmaceuticals | 8 |
| Amgen | 6 |
| Kastle Therapeutics, LLC | 6 |
| Laval University | 5 |
| University of Pennsylvania | 5 |
| CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 4 |
| Pfizer | 4 |
| Verve Therapeutics, Inc. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 224 |
| Hypercholesterolemia | 57 |
| Atherosclerosis | 22 |
| Homozygous Familial Hypercholesterolemia | 22 |
| Hyperlipidemias | 22 |
| Cardiovascular Diseases | 21 |
| Dyslipidemias | 18 |
| Genetic Diseases, Inborn | 11 |
| Metabolic Diseases | 11 |
| Hypertriglyceridemia | 10 |
Trials
Showing 76 to 100 of 224. Each trial links to its page on Pharma Observatory.
124 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.